Letter to the editor submitted in response to "efficacy and safety of imiquimod 5% cream for basal cell carcinoma: a Meta-analysis of randomised controlled trial".
Emma AxonDouglas J C GrindlayPublished in: The Journal of dermatological treatment (2019)